ישראל - עברית - Ministry of Health

kamada ltd, israel - plasma protein fraction - תמיסה לאינפוזיה - plasma protein fraction 200 mg/ml - protein c - protein c - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendation.

ישראל - עברית - Ministry of Health

dover medical & scientific equipment ltd, israel - human plasma protein - תמיסה לאינפוזיה - human plasma protein 45 - 70 mg/ml - other plasma protein fractions

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

ישראל - עברית - Ministry of Health

kamada ltd, israel - human plasma coagulation factor viii - אבקה להכנת תמיסה לזריקה - human plasma coagulation factor viii 50 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency. haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.

ישראל - עברית - Ministry of Health

kamada ltd, israel - human plasma coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - human plasma coagulation factor viii 50 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency.haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.

ישראל - עברית - Ministry of Health

kamada ltd, israel - human plasma coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - human plasma coagulation factor viii 100 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency.haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.

ישראל - עברית - Ministry of Health

dover medical & scientific equipment ltd, israel - albumin human; plasma protein fraction - תמיסה לאינפוזיה - albumin human 50 g / 1000 ml; plasma protein fraction 96 % - albumin - albumin - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate.the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on the official recommendations

ישראל - עברית - Ministry of Health

"בפקס בע""מ" - מומחה - מערכות להפשרת פלסמה קפואה

ישראל - עברית - Ministry of Health

"איילקס ביוטק בע""מ " - מומחה - "חומרים,מכשירים,אביזרים למטרת עליית בטיחות מרכיבי הדם.המערכות נועדות לעיקור מוירוסים ובקטריות של טסיות הפלזמה של הדם"

ישראל - עברית - Ministry of Health

איילקס ביוטק בע"מ - מומחה - חומרים,מכשירים,אביזרים למטרת עליית בטיחות מרכיבי הדם.המערכות נועדות לעיקור מוירוסים ובקטריות של טסיות הפלזמה של הדם